VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Iovance Biotherapeutics, Inc. (IOVA) Total Return Calculator with Dividends Reinvested

Iovance Biotherapeutics, Inc.

Popular:

The total return for Iovance Biotherapeutics, Inc. (IOVA) stock is +31.94% over the past 12 months. So far it's up 62.30% this year. The 5-year total return is -85.70%, meaning $10,000 invested in IOVA stock 5 years ago would be worth $1,430 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in IOVA 1 year ago, it would be worth $13,067 today — you'd have gained $3,067.

With Dividends Reinvested$13,067+30.67%

Price Only (No DRIP)$13,067+30.67%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in IOVA

1Y$13,194+$3,194 (+31.9%)31.9% CAGR

3Y$5,777-$4,223 (-42.2%)-16.7% CAGR

5Y$1,430-$8,570 (-85.7%)-32.2% CAGR

10Y$7,850-$2,150 (-21.5%)-2.4% CAGR

15Y$333-$9,667 (-96.7%)-20.3% CAGR

20Y$372-$9,628 (-96.3%)-15.2% CAGR

30Y$372-$9,628 (-96.3%)-10.4% CAGR

Iovance Biotherapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading IOVA total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+62.30%	—	+62.30%	—	$16,230
1Y	+31.94%	31.94%	+31.94%	—	$13,194
3Y	-42.23%	-16.72%	-42.23%	—	$5,777
5Y	-85.70%	-32.23%	-85.70%	—	$1,430
10Y	-21.50%	-2.39%	-21.50%	—	$7,850
15Y	-96.67%	-20.30%	-96.67%	—	$333
20Y	-96.28%	-15.18%	-96.28%	—	$372
30Y	-96.28%	-10.39%	-96.28%	—	$372

Risk & Highlights

Best Year+192.91%2019

Worst Year-78.00%2012

Max Drawdown-54.41%2025-07-23 → 2025-11-05 · Recovered 2026-03-04

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+53.17%	+53.17%	—	+0.41%	+52.8pp
2025	-64.96%	-64.96%	—	+16.64%	-81.6pp
2024	-8.64%	-8.64%	—	+24.00%	-32.6pp
2023	+33.06%	+33.06%	—	+24.81%	+8.2pp
2022	-66.54%	-66.54%	—	-19.95%	-46.6pp

IOVA outperformed the S&P 500 by 0.61pp over the past year (+31.94% vs +31.32%).

Loading summary...

IOVA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
IOVAIovance Biotherapeutics, Inc.	$1.7B	+23.9%	+62.3%	+31.9%	—	-42.2%	-85.7%	-21.5%
ADCTADC Therapeutics S.A.	$491M	+5.2%	+9.7%	+199.2%	—	+82.1%	-82.9%	-87.0%
FATEFate Therapeutics, Inc.	$264M	+92.4%	+131.3%	+139.1%	—	-58.0%	-97.0%	+33.9%
CRSPCRISPR Therapeutics AG	$5.3B	+12.1%	+2.4%	+66.1%	—	-1.6%	-48.9%	+290.9%
NTLAIntellia Therapeutics, Inc.	$1.6B	+4.1%	+50.4%	+91.0%	—	-67.9%	-79.2%	-37.3%
BEAMBeam Therapeutics Inc.	$3.3B	+33.4%	+19.1%	+102.2%	—	-3.0%	-53.9%	+72.4%
TGTXTG Therapeutics, Inc.	$6.7B	+24.6%	+43.3%	+20.4%	—	+26.8%	+5.3%	+425.9%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
ALNYAlnylam Pharmaceuticals, Inc.	$40.4B	-8.3%	-24.3%	+12.3%	—	+44.3%	+129.4%	+445.5%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%

Compare:IOVA vs ADCT IOVA vs FATE IOVA vs CRSP IOVA vs ADCT vs FATE

About IOVA Dividend Returns

Iovance Biotherapeutics, Inc. (IOVA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of IOVA over the past year?

Iovance Biotherapeutics, Inc. (IOVA) delivered a return of 31.94% over the past year. Since IOVA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in IOVA be worth today?

A $10,000 investment in Iovance Biotherapeutics, Inc. one year ago would be worth $13,194 today, representing a gain of $3,194.

Q3Does IOVA pay dividends?

Iovance Biotherapeutics, Inc. (IOVA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For IOVA, the total return equals the price-only return.

Q4Did IOVA beat the S&P 500?

Yes, Iovance Biotherapeutics, Inc. (IOVA) outperformed the S&P 500 by 0.61 percentage points over the past year. IOVA delivered a total return of 31.94%, compared to the S&P 500's 31.32%. This 0.61pp alpha means investors in IOVA earned more than a passive S&P 500 index fund.

Q5What is IOVA's worst drawdown?

Iovance Biotherapeutics, Inc. (IOVA) experienced a maximum drawdown of -54.41% over the past year, declining from its peak on 2025-07-23 to its trough on 2025-11-05. The stock recovered to its prior peak by 2026-03-04. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is IOVA's long-term total return over 10, 20, or 30 years?

Here are Iovance Biotherapeutics, Inc. (IOVA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -21.5% (-2.4% CAGR) — $10,000 would have grown to $7,850. Over 20 years: -96.3% total return (-15.2% CAGR) — $10,000 → $372. Over 30 years: -96.3% total return (-10.4% CAGR) — $10,000 → $372. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was IOVA's best and worst year?

Iovance Biotherapeutics, Inc.'s best calendar year was 2019 with a total return of 192.9%. Its worst year was 2012 with a total return of -78.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 270.9 percentage points.